#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Owing to the developments in biological fields , personalized diagnoses and treatments at the single cell level have become important , which will introduce new potential breakthroughs for biomedicine .
3-1	17-22	Owing	_	_	_	_
3-2	23-25	to	_	_	_	_
3-3	26-29	the	abstract[3]	new[3]	_	_
3-4	30-42	developments	abstract[3]	new[3]	_	_
3-5	43-45	in	abstract[3]	new[3]	_	_
3-6	46-56	biological	abstract[3]|abstract[4]	new[3]|new[4]	coref	13-7[98_4]
3-7	57-63	fields	abstract[3]|abstract[4]	new[3]|new[4]	_	_
3-8	64-65	,	_	_	_	_
3-9	66-78	personalized	abstract[5]	new[5]	_	_
3-10	79-88	diagnoses	abstract[5]	new[5]	_	_
3-11	89-92	and	_	_	_	_
3-12	93-103	treatments	abstract[6]	new[6]	_	_
3-13	104-106	at	abstract[6]	new[6]	_	_
3-14	107-110	the	abstract[6]|abstract[8]	new[6]|new[8]	coref	5-17[25_8]
3-15	111-117	single	abstract[6]|abstract[8]	new[6]|new[8]	_	_
3-16	118-122	cell	abstract[6]|place|abstract[8]	new[6]|new|new[8]	coref	5-8
3-17	123-128	level	abstract[6]|abstract[8]	new[6]|new[8]	_	_
3-18	129-133	have	_	_	_	_
3-19	134-140	become	_	_	_	_
3-20	141-150	important	_	_	_	_
3-21	151-152	,	_	_	_	_
3-22	153-158	which	_	_	_	_
3-23	159-163	will	_	_	_	_
3-24	164-173	introduce	_	_	_	_
3-25	174-177	new	abstract[9]	new[9]	_	_
3-26	178-187	potential	abstract[9]	new[9]	_	_
3-27	188-201	breakthroughs	abstract[9]	new[9]	_	_
3-28	202-205	for	abstract[9]	new[9]	_	_
3-29	206-217	biomedicine	abstract[9]|abstract	new[9]|new	_	_
3-30	218-219	.	_	_	_	_

#Text=Recently , the early detection of cancer and drug action on cancer have attracted considerable attention in the field of biotechnology .
4-1	220-228	Recently	_	_	_	_
4-2	229-230	,	_	_	_	_
4-3	231-234	the	event[11]	new[11]	_	_
4-4	235-240	early	event[11]	new[11]	_	_
4-5	241-250	detection	event[11]	new[11]	_	_
4-6	251-253	of	event[11]	new[11]	_	_
4-7	254-260	cancer	event[11]|abstract	new[11]|new	coref	4-12
4-8	261-264	and	_	_	_	_
4-9	265-269	drug	substance|abstract[14]	new|new[14]	coref|coref	8-21|8-21
4-10	270-276	action	abstract[14]	new[14]	_	_
4-11	277-279	on	abstract[14]	new[14]	_	_
4-12	280-286	cancer	abstract[14]|abstract	new[14]|giv	coref	6-9
4-13	287-291	have	_	_	_	_
4-14	292-301	attracted	_	_	_	_
4-15	302-314	considerable	abstract[16]	new[16]	coref	14-7[0_16]
4-16	315-324	attention	abstract[16]	new[16]	_	_
4-17	325-327	in	abstract[16]	new[16]	_	_
4-18	328-331	the	abstract[16]|abstract[17]	new[16]|new[17]	_	_
4-19	332-337	field	abstract[16]|abstract[17]	new[16]|new[17]	_	_
4-20	338-340	of	abstract[16]|abstract[17]	new[16]|new[17]	_	_
4-21	341-354	biotechnology	abstract[16]|abstract[17]|abstract	new[16]|new[17]|new	_	_
4-22	355-356	.	_	_	_	_

#Text=Microfluidic device is a useful tool in cell research with advantages such as high-throughput manipulation , high level of integration , and requirement of less time and fewer reagents .
5-1	357-369	Microfluidic	object[19]	new[19]	coref	5-4[20_19]
5-2	370-376	device	object[19]	new[19]	_	_
5-3	377-379	is	_	_	_	_
5-4	380-381	a	object[20]	giv[20]	coref	7-4[37_20]
5-5	382-388	useful	object[20]	giv[20]	_	_
5-6	389-393	tool	object[20]	giv[20]	_	_
5-7	394-396	in	object[20]	giv[20]	_	_
5-8	397-401	cell	object[20]|place|abstract[22]	giv[20]|giv|new[22]	coref|coref|coref|coref	6-10|13-20[106_22]|6-10|13-20[106_22]
5-9	402-410	research	object[20]|abstract[22]	giv[20]|new[22]	_	_
5-10	411-415	with	object[20]	giv[20]	_	_
5-11	416-426	advantages	object[20]|abstract[23]	giv[20]|new[23]	coref	16-4[123_23]
5-12	427-431	such	object[20]|abstract[23]	giv[20]|new[23]	_	_
5-13	432-434	as	object[20]|abstract[23]	giv[20]|new[23]	_	_
5-14	435-450	high-throughput	object[20]|abstract[23]|abstract[24]	giv[20]|new[23]|new[24]	_	_
5-15	451-463	manipulation	object[20]|abstract[23]|abstract[24]	giv[20]|new[23]|new[24]	_	_
5-16	464-465	,	object[20]|abstract[23]	giv[20]|new[23]	_	_
5-17	466-470	high	object[20]|abstract[23]|abstract[25]	giv[20]|new[23]|giv[25]	_	_
5-18	471-476	level	object[20]|abstract[23]|abstract[25]	giv[20]|new[23]|giv[25]	_	_
5-19	477-479	of	object[20]|abstract[23]|abstract[25]	giv[20]|new[23]|giv[25]	_	_
5-20	480-491	integration	object[20]|abstract[23]|abstract[25]|abstract	giv[20]|new[23]|giv[25]|new	_	_
5-21	492-493	,	object[20]|abstract[23]	giv[20]|new[23]	_	_
5-22	494-497	and	object[20]|abstract[23]	giv[20]|new[23]	_	_
5-23	498-509	requirement	object[20]|abstract[23]|abstract[27]	giv[20]|new[23]|new[27]	_	_
5-24	510-512	of	object[20]|abstract[23]|abstract[27]	giv[20]|new[23]|new[27]	_	_
5-25	513-517	less	object[20]|abstract[23]|abstract[27]|abstract[28]	giv[20]|new[23]|new[27]|new[28]	_	_
5-26	518-522	time	object[20]|abstract[23]|abstract[27]|abstract[28]	giv[20]|new[23]|new[27]|new[28]	_	_
5-27	523-526	and	object[20]|abstract[23]|abstract[27]	giv[20]|new[23]|new[27]	_	_
5-28	527-532	fewer	object[20]|abstract[23]|abstract[27]|abstract[29]	giv[20]|new[23]|new[27]|new[29]	_	_
5-29	533-541	reagents	object[20]|abstract[23]|abstract[27]|abstract[29]	giv[20]|new[23]|new[27]|new[29]	_	_
5-30	542-543	.	_	_	_	_

#Text=Furthermore , microfluidic devices have broad applications in cancer cell trapping .
6-1	544-555	Furthermore	_	_	_	_
6-2	556-557	,	_	_	_	_
6-3	558-570	microfluidic	object[30]	new[30]	coref	15-7[117_30]
6-4	571-578	devices	object[30]	new[30]	_	_
6-5	579-583	have	_	_	_	_
6-6	584-589	broad	abstract[31]	new[31]	_	_
6-7	590-602	applications	abstract[31]	new[31]	_	_
6-8	603-605	in	abstract[31]	new[31]	_	_
6-9	606-612	cancer	abstract[31]|abstract|abstract[34]	new[31]|giv|new[34]	coref|coref	22-24[166_34]|22-24[166_34]
6-10	613-617	cell	abstract[31]|place|abstract[34]	new[31]|giv|new[34]	coref	7-14
6-11	618-626	trapping	abstract[31]|abstract[34]	new[31]|new[34]	_	_
6-12	627-628	.	_	_	_	_

#Text=Microwell arrays in microfluidic device are often used to trap cells and construct cell arrays .
7-1	629-638	Microwell	event|object[36]	new|new[36]	coref|coref|coref|coref	7-14[40_36]|8-33|7-14[40_36]|8-33
7-2	639-645	arrays	object[36]	new[36]	_	_
7-3	646-648	in	object[36]	new[36]	_	_
7-4	649-661	microfluidic	object[36]|object[37]	new[36]|giv[37]	coref	8-4[43_37]
7-5	662-668	device	object[36]|object[37]	new[36]|giv[37]	_	_
7-6	669-672	are	_	_	_	_
7-7	673-678	often	_	_	_	_
7-8	679-683	used	_	_	_	_
7-9	684-686	to	_	_	_	_
7-10	687-691	trap	_	_	_	_
7-11	692-697	cells	object	new	coref	8-1
7-12	698-701	and	_	_	_	_
7-13	702-711	construct	_	_	_	_
7-14	712-716	cell	place|object[40]	giv|giv[40]	coref|coref|coref|coref	8-42|9-20[62_40]|8-42|9-20[62_40]
7-15	717-723	arrays	object[40]	giv[40]	_	_
7-16	724-725	.	_	_	_	_

#Text=Cells trapped in a microfluidic device can be cultured , used to detect markers , manipulated , and employed for drug screening . Rettig et al. have developed an easy-to-use method using microwell array fabricated through soft lithography for a single cell trap .
8-1	726-731	Cells	object	giv	_	_
8-2	732-739	trapped	_	_	_	_
8-3	740-742	in	_	_	_	_
8-4	743-744	a	object[43]	giv[43]	coref	10-12[76_43]
8-5	745-757	microfluidic	person|object[43]	new|giv[43]	coref	14-19
8-6	758-764	device	object[43]	giv[43]	_	_
8-7	765-768	can	_	_	_	_
8-8	769-771	be	_	_	_	_
8-9	772-780	cultured	_	_	_	_
8-10	781-782	,	_	_	_	_
8-11	783-787	used	_	_	_	_
8-12	788-790	to	_	_	_	_
8-13	791-797	detect	_	_	_	_
8-14	798-805	markers	abstract	new	_	_
8-15	806-807	,	_	_	_	_
8-16	808-819	manipulated	_	_	_	_
8-17	820-821	,	_	_	_	_
8-18	822-825	and	_	_	_	_
8-19	826-834	employed	_	_	_	_
8-20	835-838	for	_	_	_	_
8-21	839-843	drug	substance|event[46]	giv|new[46]	_	_
8-22	844-853	screening	event[46]	new[46]	_	_
8-23	854-855	.	_	_	_	_
8-24	856-862	Rettig	person	new	_	_
8-25	863-865	et	_	_	_	_
8-26	866-869	al.	_	_	_	_
8-27	870-874	have	_	_	_	_
8-28	875-884	developed	_	_	_	_
8-29	885-887	an	abstract[48]	new[48]	_	_
8-30	888-899	easy-to-use	abstract[48]	new[48]	_	_
8-31	900-906	method	abstract[48]	new[48]	_	_
8-32	907-912	using	_	_	_	_
8-33	913-922	microwell	place|place[50]	giv|new[50]	coref|coref|coref|coref	9-20|9-49[0_50]|9-20|9-49[0_50]
8-34	923-928	array	place[50]	new[50]	_	_
8-35	929-939	fabricated	_	_	_	_
8-36	940-947	through	_	_	_	_
8-37	948-952	soft	object[51]	new[51]	coref	15-11[118_51]
8-38	953-964	lithography	object[51]	new[51]	_	_
8-39	965-968	for	_	_	_	_
8-40	969-970	a	object[53]	new[53]	_	_
8-41	971-977	single	object[53]	new[53]	_	_
8-42	978-982	cell	place|object[53]	giv|new[53]	coref	9-1[54_0]
8-43	983-987	trap	object[53]	new[53]	_	_
8-44	988-989	.	_	_	_	_

#Text=Anchorage-dependent cell ( 3T3 fibroblast cells ) and anchorage-independent cell ( Basophilic leukemia cell ) were successfully trapped in microwell arrays . Lin et al. improved the traditional structure of microwells and introduced a double-well design , including a tapping well and a culturing well for single cell array construction .
9-1	990-1009	Anchorage-dependent	place[54]	giv[54]	appos	9-4[56_54]
9-2	1010-1014	cell	place[54]	giv[54]	_	_
9-3	1015-1016	(	_	_	_	_
9-4	1017-1020	3T3	place[56]	giv[56]	coref	9-9[58_56]
9-5	1021-1031	fibroblast	event|place[56]	new|giv[56]	_	_
9-6	1032-1037	cells	place[56]	giv[56]	_	_
9-7	1038-1039	)	_	_	_	_
9-8	1040-1043	and	_	_	_	_
9-9	1044-1065	anchorage-independent	person|place[58]	new|giv[58]	appos|appos	9-12[60_58]|9-12[60_58]
9-10	1066-1070	cell	place[58]	giv[58]	_	_
9-11	1071-1072	(	_	_	_	_
9-12	1073-1083	Basophilic	place[60]	giv[60]	coref	9-48[0_60]
9-13	1084-1092	leukemia	abstract|place[60]	new|giv[60]	_	_
9-14	1093-1097	cell	place[60]	giv[60]	_	_
9-15	1098-1099	)	_	_	_	_
9-16	1100-1104	were	_	_	_	_
9-17	1105-1117	successfully	_	_	_	_
9-18	1118-1125	trapped	_	_	_	_
9-19	1126-1128	in	_	_	_	_
9-20	1129-1138	microwell	event|object[62]	giv|giv[62]	coref|coref|coref|coref	11-5|14-23[115_62]|11-5|14-23[115_62]
9-21	1139-1145	arrays	object[62]	giv[62]	_	_
9-22	1146-1147	.	_	_	_	_
9-23	1148-1151	Lin	person	new	_	_
9-24	1152-1154	et	_	_	_	_
9-25	1155-1158	al.	_	_	_	_
9-26	1159-1167	improved	_	_	_	_
9-27	1168-1171	the	abstract[64]	new[64]	_	_
9-28	1172-1183	traditional	abstract[64]	new[64]	_	_
9-29	1184-1193	structure	abstract[64]	new[64]	_	_
9-30	1194-1196	of	abstract[64]	new[64]	_	_
9-31	1197-1207	microwells	abstract[64]|object	new[64]|new	coref	12-16[95_0]
9-32	1208-1211	and	_	_	_	_
9-33	1212-1222	introduced	_	_	_	_
9-34	1223-1224	a	abstract[66]	new[66]	_	_
9-35	1225-1236	double-well	abstract[66]	new[66]	_	_
9-36	1237-1243	design	abstract[66]	new[66]	_	_
9-37	1244-1245	,	abstract[66]	new[66]	_	_
9-38	1246-1255	including	abstract[66]	new[66]	_	_
9-39	1256-1257	a	abstract[66]	new[66]	_	_
9-40	1258-1265	tapping	abstract[66]	new[66]	_	_
9-41	1266-1270	well	abstract[66]	new[66]	_	_
9-42	1271-1274	and	abstract[66]	new[66]	_	_
9-43	1275-1276	a	abstract[66]|abstract[67]	new[66]|new[67]	_	_
9-44	1277-1286	culturing	abstract[66]|abstract[67]	new[66]|new[67]	_	_
9-45	1287-1291	well	abstract[66]|abstract[67]	new[66]|new[67]	_	_
9-46	1292-1295	for	abstract[66]|abstract[67]	new[66]|new[67]	_	_
9-47	1296-1302	single	abstract[66]|abstract[67]|abstract[70]	new[66]|new[67]|new[70]	_	_
9-48	1303-1307	cell	abstract[66]|abstract[67]|place|abstract[70]	new[66]|new[67]|giv|new[70]	coref	10-3
9-49	1308-1313	array	abstract[66]|abstract[67]|place|abstract[70]	new[66]|new[67]|giv|new[70]	coref	11-3[79_0]
9-50	1314-1326	construction	abstract[66]|abstract[67]|abstract[70]	new[66]|new[67]|new[70]	_	_
9-51	1327-1328	.	_	_	_	_

#Text=Neural stem cell differentiation and A549 cell proliferation were performed using this device .
10-1	1329-1335	Neural	event[73]	new[73]	_	_
10-2	1336-1340	stem	plant|event[73]	new|new[73]	_	_
10-3	1341-1345	cell	place|event[73]	giv|new[73]	coref	10-7
10-4	1346-1361	differentiation	event[73]	new[73]	_	_
10-5	1362-1365	and	_	_	_	_
10-6	1366-1370	A549	event[75]	new[75]	coref	13-13[102_75]
10-7	1371-1375	cell	place|event[75]	giv|new[75]	coref	12-1[91_0]
10-8	1376-1389	proliferation	event[75]	new[75]	_	_
10-9	1390-1394	were	_	_	_	_
10-10	1395-1404	performed	_	_	_	_
10-11	1405-1410	using	_	_	_	_
10-12	1411-1415	this	object[76]	giv[76]	coref	13-1[97_76]
10-13	1416-1422	device	object[76]	giv[76]	_	_
10-14	1423-1424	.	_	_	_	_

#Text=Assal constructed a 3D microwell array using polyethylene glycol ( PEG ) solution cured by ultraviolet ( UV ) light based on a polydimethylsiloxane ( PDMS ) mold .
11-1	1425-1430	Assal	person	new	_	_
11-2	1431-1442	constructed	_	_	_	_
11-3	1443-1444	a	place[79]	giv[79]	_	_
11-4	1445-1447	3D	place[79]	giv[79]	_	_
11-5	1448-1457	microwell	object|place[79]	giv|giv[79]	coref	14-23
11-6	1458-1463	array	place[79]	giv[79]	_	_
11-7	1464-1469	using	_	_	_	_
11-8	1470-1482	polyethylene	substance|object[81]	new|new[81]	appos|appos	11-11[0_81]|11-11[0_81]
11-9	1483-1489	glycol	object[81]	new[81]	_	_
11-10	1490-1491	(	_	_	_	_
11-11	1492-1495	PEG	object	giv	coref	24-1[173_0]
11-12	1496-1497	)	_	_	_	_
11-13	1498-1506	solution	substance	new	_	_
11-14	1507-1512	cured	_	_	_	_
11-15	1513-1515	by	_	_	_	_
11-16	1516-1527	ultraviolet	abstract	new	appos	11-18
11-17	1528-1529	(	_	_	_	_
11-18	1530-1532	UV	abstract	giv	_	_
11-19	1533-1534	)	_	_	_	_
11-20	1535-1540	light	abstract	new	_	_
11-21	1541-1546	based	_	_	_	_
11-22	1547-1549	on	_	_	_	_
11-23	1550-1551	a	object[87]|object[89]	new[87]|new[89]	appos|coref|appos|coref	11-26[0_87]|18-10[137_89]|11-26[0_87]|18-10[137_89]
11-24	1552-1572	polydimethylsiloxane	object[87]|object[89]	new[87]|new[89]	_	_
11-25	1573-1574	(	object[89]	new[89]	_	_
11-26	1575-1579	PDMS	object|object[89]	giv|new[89]	_	_
11-27	1580-1581	)	object[89]	new[89]	_	_
11-28	1582-1586	mold	object[89]	new[89]	_	_
11-29	1587-1588	.	_	_	_	_

#Text=Human B cells infected by Kaposi ’s sarcoma-associated herpesvirus ( KSHV ) were trapped in these microwells for 3D culture .
12-1	1589-1594	Human	place[91]	giv[91]	coref	13-10[0_91]
12-2	1595-1596	B	person|place[91]	new|giv[91]	_	_
12-3	1597-1602	cells	place[91]	giv[91]	_	_
12-4	1603-1611	infected	_	_	_	_
12-5	1612-1614	by	_	_	_	_
12-6	1615-1621	Kaposi	person[92]|object[93]	new[92]|new[93]	appos|appos	12-11[0_93]|12-11[0_93]
12-7	1622-1624	’s	person[92]|object[93]	new[92]|new[93]	_	_
12-8	1625-1643	sarcoma-associated	object[93]	new[93]	_	_
12-9	1644-1655	herpesvirus	object[93]	new[93]	_	_
12-10	1656-1657	(	_	_	_	_
12-11	1658-1662	KSHV	object	giv	_	_
12-12	1663-1664	)	_	_	_	_
12-13	1665-1669	were	_	_	_	_
12-14	1670-1677	trapped	_	_	_	_
12-15	1678-1680	in	_	_	_	_
12-16	1681-1686	these	object[95]	giv[95]	_	_
12-17	1687-1697	microwells	object[95]	giv[95]	_	_
12-18	1698-1701	for	object[95]	giv[95]	_	_
12-19	1702-1704	3D	object[95]|abstract[96]	giv[95]|new[96]	_	_
12-20	1705-1712	culture	object[95]|abstract[96]	giv[95]|new[96]	_	_
12-21	1713-1714	.	_	_	_	_

#Text=Microfluidic device has been applied in various fields for cell separation , cell proliferation , and cell behavior in biology research .
13-1	1715-1727	Microfluidic	object[97]	giv[97]	ana	14-4[0_97]
13-2	1728-1734	device	object[97]	giv[97]	_	_
13-3	1735-1738	has	_	_	_	_
13-4	1739-1743	been	_	_	_	_
13-5	1744-1751	applied	_	_	_	_
13-6	1752-1754	in	_	_	_	_
13-7	1755-1762	various	abstract[98]	giv[98]	_	_
13-8	1763-1769	fields	abstract[98]	giv[98]	_	_
13-9	1770-1773	for	abstract[98]	giv[98]	_	_
13-10	1774-1778	cell	abstract[98]|place|event[100]	giv[98]|giv|new[100]	coref|coref|coref|coref	13-13|22-21[164_100]|13-13|22-21[164_100]
13-11	1779-1789	separation	abstract[98]|event[100]	giv[98]|new[100]	_	_
13-12	1790-1791	,	abstract[98]	giv[98]	_	_
13-13	1792-1796	cell	abstract[98]|place|event[102]	giv[98]|giv|giv[102]	coref|coref	13-17|13-17
13-14	1797-1810	proliferation	abstract[98]|event[102]	giv[98]|giv[102]	_	_
13-15	1811-1812	,	abstract[98]	giv[98]	_	_
13-16	1813-1816	and	abstract[98]	giv[98]	_	_
13-17	1817-1821	cell	abstract[98]|place|abstract[104]	giv[98]|giv|new[104]	coref|coref	14-14|14-14
13-18	1822-1830	behavior	abstract[98]|abstract[104]	giv[98]|new[104]	_	_
13-19	1831-1833	in	abstract[98]|abstract[104]	giv[98]|new[104]	_	_
13-20	1834-1841	biology	abstract[98]|abstract[104]|abstract|abstract[106]	giv[98]|new[104]|new|giv[106]	_	_
13-21	1842-1850	research	abstract[98]|abstract[104]|abstract[106]	giv[98]|new[104]|giv[106]	_	_
13-22	1851-1852	.	_	_	_	_

#Text=In particular , it has received attention for the in situ characterization of cells after trapping them using microfluidic device equipped with microwell arrays .
14-1	1853-1855	In	_	_	_	_
14-2	1856-1866	particular	_	_	_	_
14-3	1867-1868	,	_	_	_	_
14-4	1869-1871	it	object	giv	coref	14-19[113_0]
14-5	1872-1875	has	_	_	_	_
14-6	1876-1884	received	_	_	_	_
14-7	1885-1894	attention	abstract	giv	_	_
14-8	1895-1898	for	_	_	_	_
14-9	1899-1902	the	abstract[109]	new[109]	_	_
14-10	1903-1905	in	abstract[109]	new[109]	_	_
14-11	1906-1910	situ	abstract[109]	new[109]	_	_
14-12	1911-1927	characterization	abstract[109]	new[109]	_	_
14-13	1928-1930	of	abstract[109]	new[109]	_	_
14-14	1931-1936	cells	abstract[109]|place	new[109]|giv	ana	14-17
14-15	1937-1942	after	_	_	_	_
14-16	1943-1951	trapping	_	_	_	_
14-17	1952-1956	them	place	giv	coref	22-21
14-18	1957-1962	using	_	_	_	_
14-19	1963-1975	microfluidic	person|object[113]	giv|giv[113]	coref|coref|coref|coref	17-10|17-11[0_113]|17-10|17-11[0_113]
14-20	1976-1982	device	object[113]	giv[113]	_	_
14-21	1983-1991	equipped	_	_	_	_
14-22	1992-1996	with	_	_	_	_
14-23	1997-2006	microwell	object|object[115]	giv|giv[115]	coref|coref|coref|coref	27-3|27-3[189_115]|27-3|27-3[189_115]
14-24	2007-2013	arrays	object[115]	giv[115]	_	_
14-25	2014-2015	.	_	_	_	_

#Text=There are traditional methods for fabricating microfluidic devices such as soft lithography , photolithography , and laser direct writing .
15-1	2016-2021	There	_	_	_	_
15-2	2022-2025	are	_	_	_	_
15-3	2026-2037	traditional	abstract[116]	new[116]	coref	21-13[154_116]
15-4	2038-2045	methods	abstract[116]	new[116]	_	_
15-5	2046-2049	for	_	_	_	_
15-6	2050-2061	fabricating	_	_	_	_
15-7	2062-2074	microfluidic	object[117]	giv[117]	coref	21-18[156_117]
15-8	2075-2082	devices	object[117]	giv[117]	_	_
15-9	2083-2087	such	object[117]	giv[117]	_	_
15-10	2088-2090	as	object[117]	giv[117]	_	_
15-11	2091-2095	soft	object[117]|object[118]	giv[117]|giv[118]	coref	17-1[130_118]
15-12	2096-2107	lithography	object[117]|object[118]	giv[117]|giv[118]	_	_
15-13	2108-2109	,	object[117]	giv[117]	_	_
15-14	2110-2126	photolithography	object[117]|object	giv[117]|new	coref	16-2
15-15	2127-2128	,	object[117]	giv[117]	_	_
15-16	2129-2132	and	object[117]	giv[117]	_	_
15-17	2133-2138	laser	object[117]|person|abstract[121]	giv[117]|new|new[121]	coref|coref|coref|coref	19-1|19-1[141_121]|19-1|19-1[141_121]
15-18	2139-2145	direct	object[117]|abstract[121]	giv[117]|new[121]	_	_
15-19	2146-2153	writing	object[117]|abstract[121]	giv[117]|new[121]	_	_
15-20	2154-2155	.	_	_	_	_

#Text=Although photolithography has the advantages of high resolution , a physical mask is essential during the fabrication process , and this technique requires extreme environmental conditions .
16-1	2156-2164	Although	_	_	_	_
16-2	2165-2181	photolithography	object	giv	_	_
16-3	2182-2185	has	_	_	_	_
16-4	2186-2189	the	abstract[123]	giv[123]	_	_
16-5	2190-2200	advantages	abstract[123]	giv[123]	_	_
16-6	2201-2203	of	abstract[123]	giv[123]	_	_
16-7	2204-2208	high	abstract[123]|abstract[124]	giv[123]|new[124]	_	_
16-8	2209-2219	resolution	abstract[123]|abstract[124]	giv[123]|new[124]	_	_
16-9	2220-2221	,	_	_	_	_
16-10	2222-2223	a	object[125]	new[125]	_	_
16-11	2224-2232	physical	object[125]	new[125]	_	_
16-12	2233-2237	mask	object[125]	new[125]	_	_
16-13	2238-2240	is	_	_	_	_
16-14	2241-2250	essential	_	_	_	_
16-15	2251-2257	during	_	_	_	_
16-16	2258-2261	the	event[127]	new[127]	_	_
16-17	2262-2273	fabrication	abstract|event[127]	new|new[127]	coref	17-10[133_0]
16-18	2274-2281	process	event[127]	new[127]	_	_
16-19	2282-2283	,	_	_	_	_
16-20	2284-2287	and	_	_	_	_
16-21	2288-2292	this	abstract[128]	new[128]	coref	22-8[159_128]
16-22	2293-2302	technique	abstract[128]	new[128]	_	_
16-23	2303-2311	requires	_	_	_	_
16-24	2312-2319	extreme	abstract[129]	new[129]	_	_
16-25	2320-2333	environmental	abstract[129]	new[129]	_	_
16-26	2334-2344	conditions	abstract[129]	new[129]	_	_
16-27	2345-2346	.	_	_	_	_

#Text=Soft lithography has been successfully and widely applied to microfluidic device fabrication .
17-1	2347-2351	Soft	abstract[130]	giv[130]	coref	23-7[169_130]
17-2	2352-2363	lithography	abstract[130]	giv[130]	_	_
17-3	2364-2367	has	_	_	_	_
17-4	2368-2372	been	_	_	_	_
17-5	2373-2385	successfully	_	_	_	_
17-6	2386-2389	and	_	_	_	_
17-7	2390-2396	widely	_	_	_	_
17-8	2397-2404	applied	_	_	_	_
17-9	2405-2407	to	_	_	_	_
17-10	2408-2420	microfluidic	person|abstract[133]	giv|giv[133]	ana|coref|ana|coref	18-2[0_133]|21-18|18-2[0_133]|21-18
17-11	2421-2427	device	object|abstract[133]	giv|giv[133]	coref	25-17[184_0]
17-12	2428-2439	fabrication	abstract[133]	giv[133]	_	_
17-13	2440-2441	.	_	_	_	_

#Text=While it is an easy-to-use approach , it requires a pre-designed mold or stamp , making it considerably time-consuming .
18-1	2442-2447	While	_	_	_	_
18-2	2448-2450	it	abstract	giv	coref	18-4[135_0]
18-3	2451-2453	is	_	_	_	_
18-4	2454-2456	an	abstract[135]	giv[135]	ana	18-8[0_135]
18-5	2457-2468	easy-to-use	abstract[135]	giv[135]	_	_
18-6	2469-2477	approach	abstract[135]	giv[135]	_	_
18-7	2478-2479	,	_	_	_	_
18-8	2480-2482	it	abstract	giv	ana	18-17
18-9	2483-2491	requires	_	_	_	_
18-10	2492-2493	a	object[137]	giv[137]	_	_
18-11	2494-2506	pre-designed	object[137]	giv[137]	_	_
18-12	2507-2511	mold	object[137]	giv[137]	_	_
18-13	2512-2514	or	_	_	_	_
18-14	2515-2520	stamp	object	new	_	_
18-15	2521-2522	,	_	_	_	_
18-16	2523-2529	making	_	_	_	_
18-17	2530-2532	it	abstract	giv	coref	23-11[170_0]
18-18	2533-2545	considerably	_	_	_	_
18-19	2546-2560	time-consuming	_	_	_	_
18-20	2561-2562	.	_	_	_	_

#Text=Laser direct writing can fabricate complicated 3D microstructures without the need of photomasks owing to its high-resolution and flexibility .
19-1	2563-2568	Laser	person|object[141]	giv|giv[141]	_	_
19-2	2569-2575	direct	object[141]	giv[141]	_	_
19-3	2576-2583	writing	object[141]	giv[141]	_	_
19-4	2584-2587	can	_	_	_	_
19-5	2588-2597	fabricate	_	_	_	_
19-6	2598-2609	complicated	object[143]	new[143]	coref	24-14[0_143]
19-7	2610-2612	3D	abstract|object[143]	new|new[143]	_	_
19-8	2613-2628	microstructures	object[143]	new[143]	_	_
19-9	2629-2636	without	object[143]	new[143]	_	_
19-10	2637-2640	the	object[143]|abstract[144]	new[143]|new[144]	ana	19-16[0_144]
19-11	2641-2645	need	object[143]|abstract[144]	new[143]|new[144]	_	_
19-12	2646-2648	of	object[143]|abstract[144]	new[143]|new[144]	_	_
19-13	2649-2659	photomasks	object[143]|abstract[144]|object	new[143]|new[144]|new	_	_
19-14	2660-2665	owing	_	_	_	_
19-15	2666-2668	to	_	_	_	_
19-16	2669-2672	its	abstract|abstract[147]	giv|new[147]	_	_
19-17	2673-2688	high-resolution	abstract[147]	new[147]	_	_
19-18	2689-2692	and	_	_	_	_
19-19	2693-2704	flexibility	abstract	new	_	_
19-20	2705-2706	.	_	_	_	_

#Text=However , the linear scanning mode is time-consuming .
20-1	2707-2714	However	_	_	_	_
20-2	2715-2716	,	_	_	_	_
20-3	2717-2720	the	abstract[150]	new[150]	_	_
20-4	2721-2727	linear	abstract[150]	new[150]	_	_
20-5	2728-2736	scanning	abstract|abstract[150]	new|new[150]	_	_
20-6	2737-2741	mode	abstract[150]	new[150]	_	_
20-7	2742-2744	is	_	_	_	_
20-8	2745-2759	time-consuming	_	_	_	_
20-9	2760-2761	.	_	_	_	_

#Text=Therefore , tedious procedures and high-cost equipment are the main challenges of the current methods for fabricating microfluidic devices .
21-1	2762-2771	Therefore	_	_	_	_
21-2	2772-2773	,	_	_	_	_
21-3	2774-2781	tedious	abstract[151]	new[151]	_	_
21-4	2782-2792	procedures	abstract[151]	new[151]	_	_
21-5	2793-2796	and	_	_	_	_
21-6	2797-2806	high-cost	abstract[152]	new[152]	coref	21-9[153_152]
21-7	2807-2816	equipment	abstract[152]	new[152]	_	_
21-8	2817-2820	are	_	_	_	_
21-9	2821-2824	the	abstract[153]	giv[153]	_	_
21-10	2825-2829	main	abstract[153]	giv[153]	_	_
21-11	2830-2840	challenges	abstract[153]	giv[153]	_	_
21-12	2841-2843	of	abstract[153]	giv[153]	_	_
21-13	2844-2847	the	abstract[153]|abstract[154]	giv[153]|giv[154]	coref	26-3[186_154]
21-14	2848-2855	current	abstract[153]|abstract[154]	giv[153]|giv[154]	_	_
21-15	2856-2863	methods	abstract[153]|abstract[154]	giv[153]|giv[154]	_	_
21-16	2864-2867	for	_	_	_	_
21-17	2868-2879	fabricating	_	_	_	_
21-18	2880-2892	microfluidic	person|object[156]	giv|giv[156]	coref|coref|coref|coref	22-13|22-13[161_156]|22-13|22-13[161_156]
21-19	2893-2900	devices	object[156]	giv[156]	_	_
21-20	2901-2902	.	_	_	_	_

#Text=Thus , it is crucial to develop a facile technique for creating microfluidic devices that can satisfy the requirements of cell separation and cell trapping .
22-1	2903-2907	Thus	_	_	_	_
22-2	2908-2909	,	_	_	_	_
22-3	2910-2912	it	event	new	cata	22-3[0_158]
22-4	2913-2915	is	_	_	_	_
22-5	2916-2923	crucial	_	_	_	_
22-6	2924-2926	to	event[158]	new[158]	_	_
22-7	2927-2934	develop	event[158]	new[158]	_	_
22-8	2935-2936	a	event[158]|abstract[159]	new[158]|giv[159]	_	_
22-9	2937-2943	facile	event[158]|abstract[159]	new[158]|giv[159]	_	_
22-10	2944-2953	technique	event[158]|abstract[159]	new[158]|giv[159]	_	_
22-11	2954-2957	for	_	_	_	_
22-12	2958-2966	creating	_	_	_	_
22-13	2967-2979	microfluidic	person|object[161]	giv|giv[161]	coref|coref|coref|coref	23-14[171_161]|27-15|23-14[171_161]|27-15
22-14	2980-2987	devices	object[161]	giv[161]	_	_
22-15	2988-2992	that	_	_	_	_
22-16	2993-2996	can	_	_	_	_
22-17	2997-3004	satisfy	_	_	_	_
22-18	3005-3008	the	abstract[162]	new[162]	_	_
22-19	3009-3021	requirements	abstract[162]	new[162]	_	_
22-20	3022-3024	of	abstract[162]	new[162]	_	_
22-21	3025-3029	cell	abstract[162]|place|abstract[164]	new[162]|giv|giv[164]	coref|coref	22-24|22-24
22-22	3030-3040	separation	abstract[162]|abstract[164]	new[162]|giv[164]	_	_
22-23	3041-3044	and	abstract[162]	new[162]	_	_
22-24	3045-3049	cell	abstract[162]|place|abstract[166]	new[162]|giv|giv[166]	_	_
22-25	3050-3058	trapping	abstract[162]|abstract[166]	new[162]|giv[166]	_	_
22-26	3059-3060	.	_	_	_	_

#Text=In this paper , we present optofluidic maskless lithography for rapid fabrication of microfluidic devices .
23-1	3061-3063	In	_	_	_	_
23-2	3064-3068	this	abstract[167]	new[167]	_	_
23-3	3069-3074	paper	abstract[167]	new[167]	_	_
23-4	3075-3076	,	_	_	_	_
23-5	3077-3079	we	person	acc	_	_
23-6	3080-3087	present	_	_	_	_
23-7	3088-3099	optofluidic	object[169]	giv[169]	_	_
23-8	3100-3108	maskless	object[169]	giv[169]	_	_
23-9	3109-3120	lithography	object[169]	giv[169]	_	_
23-10	3121-3124	for	_	_	_	_
23-11	3125-3130	rapid	abstract[170]	giv[170]	coref	24-14[176_170]
23-12	3131-3142	fabrication	abstract[170]	giv[170]	_	_
23-13	3143-3145	of	abstract[170]	giv[170]	_	_
23-14	3146-3158	microfluidic	abstract[170]|object[171]	giv[170]|giv[171]	_	_
23-15	3159-3166	devices	abstract[170]|object[171]	giv[170]|giv[171]	_	_
23-16	3167-3168	.	_	_	_	_

#Text=Poly(ethylene glycol ) diacrylate ( PEGDMA ) was selected as the material for microstructures fabrication , and the cured microstructures were firmly adhered to the substrate .
24-1	3169-3182	Poly(ethylene	substance|object[173]	new|giv[173]	_	_
24-2	3183-3189	glycol	object[173]	giv[173]	_	_
24-3	3190-3191	)	_	_	_	_
24-4	3192-3202	diacrylate	_	_	_	_
24-5	3203-3204	(	_	_	_	_
24-6	3205-3211	PEGDMA	object	new	_	_
24-7	3212-3213	)	_	_	_	_
24-8	3214-3217	was	_	_	_	_
24-9	3218-3226	selected	_	_	_	_
24-10	3227-3229	as	_	_	_	_
24-11	3230-3233	the	_	_	_	_
24-12	3234-3242	material	_	_	_	_
24-13	3243-3246	for	_	_	_	_
24-14	3247-3262	microstructures	object|abstract[176]	giv|giv[176]	coref|coref	24-18[177_0]|24-18[177_0]
24-15	3263-3274	fabrication	abstract[176]	giv[176]	_	_
24-16	3275-3276	,	_	_	_	_
24-17	3277-3280	and	_	_	_	_
24-18	3281-3284	the	object[177]	giv[177]	_	_
24-19	3285-3290	cured	object[177]	giv[177]	_	_
24-20	3291-3306	microstructures	object[177]	giv[177]	_	_
24-21	3307-3311	were	_	_	_	_
24-22	3312-3318	firmly	_	_	_	_
24-23	3319-3326	adhered	_	_	_	_
24-24	3327-3329	to	_	_	_	_
24-25	3330-3333	the	object[178]	new[178]	_	_
24-26	3334-3343	substrate	object[178]	new[178]	_	_
24-27	3344-3345	.	_	_	_	_

#Text=The structures of microfluidic chips were on-line designed , and the exposure patterns were modulated by digital micromirror device ( DMD ) .
25-1	3346-3349	The	abstract[179]	new[179]	_	_
25-2	3350-3360	structures	abstract[179]	new[179]	_	_
25-3	3361-3363	of	abstract[179]	new[179]	_	_
25-4	3364-3376	microfluidic	abstract[179]|object[180]	new[179]|new[180]	_	_
25-5	3377-3382	chips	abstract[179]|object[180]	new[179]|new[180]	_	_
25-6	3383-3387	were	_	_	_	_
25-7	3388-3395	on-line	_	_	_	_
25-8	3396-3404	designed	_	_	_	_
25-9	3405-3406	,	_	_	_	_
25-10	3407-3410	and	_	_	_	_
25-11	3411-3414	the	abstract[182]	new[182]	_	_
25-12	3415-3423	exposure	abstract|abstract[182]	new|new[182]	_	_
25-13	3424-3432	patterns	abstract[182]	new[182]	_	_
25-14	3433-3437	were	_	_	_	_
25-15	3438-3447	modulated	_	_	_	_
25-16	3448-3450	by	_	_	_	_
25-17	3451-3458	digital	object[184]	giv[184]	_	_
25-18	3459-3470	micromirror	object|object[184]	new|giv[184]	_	_
25-19	3471-3477	device	object[184]	giv[184]	_	_
25-20	3478-3479	(	_	_	_	_
25-21	3480-3483	DMD	abstract	new	_	_
25-22	3484-3485	)	_	_	_	_
25-23	3486-3487	.	_	_	_	_

#Text=Compared with traditional methods , the proposed system is more flexible and cost-efficient .
26-1	3488-3496	Compared	_	_	_	_
26-2	3497-3501	with	_	_	_	_
26-3	3502-3513	traditional	abstract[186]	giv[186]	_	_
26-4	3514-3521	methods	abstract[186]	giv[186]	_	_
26-5	3522-3523	,	_	_	_	_
26-6	3524-3527	the	abstract[187]	new[187]	_	_
26-7	3528-3536	proposed	abstract[187]	new[187]	_	_
26-8	3537-3543	system	abstract[187]	new[187]	_	_
26-9	3544-3546	is	_	_	_	_
26-10	3547-3551	more	_	_	_	_
26-11	3552-3560	flexible	_	_	_	_
26-12	3561-3564	and	_	_	_	_
26-13	3565-3579	cost-efficient	_	_	_	_
26-14	3580-3581	.	_	_	_	_

#Text=Furthermore , microwell arrays with various shapes and sizes can be constructed on the microfluidic chip .
27-1	3582-3593	Furthermore	_	_	_	_
27-2	3594-3595	,	_	_	_	_
27-3	3596-3605	microwell	event|object[189]	giv|giv[189]	_	_
27-4	3606-3612	arrays	object[189]	giv[189]	_	_
27-5	3613-3617	with	object[189]	giv[189]	_	_
27-6	3618-3625	various	object[189]|abstract[190]	giv[189]|new[190]	_	_
27-7	3626-3632	shapes	object[189]|abstract[190]	giv[189]|new[190]	_	_
27-8	3633-3636	and	object[189]	giv[189]	_	_
27-9	3637-3642	sizes	object[189]|quantity	giv[189]|new	_	_
27-10	3643-3646	can	_	_	_	_
27-11	3647-3649	be	_	_	_	_
27-12	3650-3661	constructed	_	_	_	_
27-13	3662-3664	on	_	_	_	_
27-14	3665-3668	the	object[193]	new[193]	_	_
27-15	3669-3681	microfluidic	person|object[193]	giv|new[193]	_	_
27-16	3682-3686	chip	object[193]	new[193]	_	_
27-17	3687-3688	.	_	_	_	_
